Literature DB >> 15228717

Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.

K Awadzi1, S K Attah, E T Addy, N O Opoku, B T Quartey, J K Lazdins-Helds, K Ahmed, B A Boatin, D A Boakye, G Edwards.   

Abstract

The pathogenesis of the sub-optimal response of Onchocerca volvulus to ivermectin was investigated in a 30-month follow-up of 28 individuals who, in a previous study, had been found to show a sub-optimal (N = 15) or adequate response (N = 13) to multiple treatments with the drug. Verbal informed consent was obtained before each subject was given a general clinical and ocular examination. Skin snips were taken from both iliac crests and both calves. Seventeen nodule carriers were hospitalized for nodulectomy. Adult worms were harvested, embryogrammes were constructed and all developmental stages were counted; degenerate, stretched microfilariae were noted separately. All the subjects were in good general health and all except one had received at least one additional treatment with ivermectin since the earlier study. A large proportion of the adult female worms in 10 out of the 11 sub-optimal responders who were nodule carriers were in full embryonic production but most of the stretched microfilariae they carried were degenerate. This picture is similar to that found in adult worms exposed to the first dose of ivermectin. In one subject who had no viable worms in his nodules, the existence of occult but actively reproductive worms was inferred from the high level of microfilaridermia observed less than 12 months after treatment. These observations confirm the existence of populations of adult female O. volvulus that respond poorly to repeated doses of ivermectin. The use of suramin in the treatment of the sub-optimal responders is discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15228717     DOI: 10.1179/000349804225003442

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  53 in total

1.  The role of Brugia malayi ATP-binding cassette (ABC) transporters in potentiating drug sensitivity.

Authors:  Jeffrey B Tompkins; Laurel E Stitt; Alana M Morrissette; Bernadette F Ardelli
Journal:  Parasitol Res       Date:  2011-04-15       Impact factor: 2.289

2.  Wolbachia in filarial parasites: targets for filarial infection and disease control.

Authors:  Kelly L Johnston; Mark J Taylor
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

3.  Identifying sub-optimal responses to ivermectin in the treatment of River Blindness.

Authors:  Thomas S Churcher; Sébastien D S Pion; Mike Y Osei-Atweneboana; Roger K Prichard; Kwablah Awadzi; Michel Boussinesq; Richard C Collins; James A Whitworth; María-Gloria Basáñez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-17       Impact factor: 11.205

4.  Analysis of transcriptional regulation of tetracycline responsive genes in Brugia malayi.

Authors:  Canhui Liu; Patrick Vander Kelen; Elodie Ghedin; Sara Lustigman; Thomas R Unnasch
Journal:  Mol Biochem Parasitol       Date:  2011-09-16       Impact factor: 1.759

5.  Vaccines to combat river blindness: expression, selection and formulation of vaccines against infection with Onchocerca volvulus in a mouse model.

Authors:  Jessica A Hess; Bin Zhan; Sandra Bonne-Année; Jessica M Deckman; Maria Elena Bottazzi; Peter J Hotez; Thomas R Klei; Sara Lustigman; David Abraham
Journal:  Int J Parasitol       Date:  2014-06-05       Impact factor: 3.981

6.  Assembling Pharma Resources to Tackle Diseases of Underserved Populations.

Authors:  Dale J Kempf; Kennan C Marsh
Journal:  ACS Med Chem Lett       Date:  2020-03-27       Impact factor: 4.345

7.  Repositioning of an existing drug for the neglected tropical disease Onchocerciasis.

Authors:  Christian Gloeckner; Amanda L Garner; Fana Mersha; Yelena Oksov; Nancy Tricoche; Lisa M Eubanks; Sara Lustigman; Gunnar F Kaufmann; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

8.  Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus.

Authors:  Achim Hoerauf; Sabine Specht; Yeboah Marfo-Debrekyei; Marcelle Büttner; Alexander Yaw Debrah; Sabine Mand; Linda Batsa; Norbert Brattig; Peter Konadu; Claudio Bandi; Rolf Fimmers; Ohene Adjei; Dietrich W Büttner
Journal:  Parasitol Res       Date:  2008-10-11       Impact factor: 2.289

9.  Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon.

Authors:  Samuel Wanji; Nicholas Tendongfor; Theolbald Nji; Mathias Esum; Julious N Che; Armand Nkwescheu; Fifen Alassa; Geremy Kamnang; Peter A Enyong; Mark J Taylor; Achim Hoerauf; David W Taylor
Journal:  Parasit Vectors       Date:  2009-08-27       Impact factor: 3.876

10.  Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study.

Authors:  Achim Hoerauf; Sabine Specht; Marcelle Büttner; Kenneth Pfarr; Sabine Mand; Rolf Fimmers; Yeboah Marfo-Debrekyei; Peter Konadu; Alexander Yaw Debrah; Claudio Bandi; Norbert Brattig; Anna Albers; John Larbi; Linda Batsa; Mark J Taylor; Ohene Adjei; Dietrich W Büttner
Journal:  Med Microbiol Immunol       Date:  2007-11-13       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.